Home heart monitoring
This article was originally published in The Gray Sheet
Executive Summary
Tracking pacemaker and defibrillator recipients with Biotronik's wireless home monitoring system reduces direct patient care costs 12% and associated indirect costs 26% annually per patient, according to cost-efficacy models presented May 9 by Antonio Chan, MD, Stanford University, at the NASPE annual meeting in San Diego. Over seven years, the technology could save an average of $700 per patient annually, saving Medicare up to $121 mil. per year, Chan concludes. The communications system is incorporated into Biotronik's Belos VR-T ICD and Philos DR-T pacemaker, approved April 24 and April 2, respectively. In a 100-patient multicenter trial, the Philos DR-T transmitted key cardiac data via a German call center to a physician on 92.3% of attempts, usually within one minute, according to Chan....
You may also be interested in...
California Court’s Inaction On TiO2 Prop 65 First Amendment Case Breeds New Lawsuits
The Personal Care Products Council seeks to stem the rising tide of titanium dioxide Proposition 65 lawsuits, requesting that a California court prohibit the state’s Attorney General and private enforcers from filing and/or prosecuting new suits against cosmetics companies failing to warn about potential TiO2 exposure.
Kenvue Breaks Ground On New Headquarters, Appoints Chief Corporate Affairs Officer
Firm hosts groundbreaking for 290,000 square-foot global headquarters it’s having built in Summit, NJ, starting with 100,000 square-foot science and innovation and expected to open in 2025. It announced adding Russell Dyer as chief corporate affairs officer starting 13 March.
Xaira Launches With $1bn-Plus And End-To-End AI Strategy
ARCH and Foresite incubated the company and recruited Genentech R&D veteran Marc Tessier-Lavigne to keep data generation, machine learning research and drug development under one roof.